Source: http://uscode.house.gov/view.xhtml?req=(title:42%20section:1395w-3%20edition:prelim)
Timestamp: 2017-03-26 12:58:13
Document Index: 11651514

Matched Legal Cases: ['§ 1395', '§1847', '§4319', '§1000', '§321', '§302', '§145', '§6410', '§522', '§5004', '§301', '§1847', '§202', '§608', '§201', '§522', '§302', '§154', '§302', '§154', '§4319']

42 USC 1395w-3: Competitive acquisition of certain items and services
TITLE 42 / CHAPTER 7 / SUBCHAPTER XVIII / Part B / § 1395w-3
Text contains those laws in effect on March 25, 2017
With respect to the competitive acquisition program for diabetic testing strips conducted after the first round of the competitive acquisition programs, if an entity does not demonstrate to the Secretary that its bid covers types of diabetic testing strip products that, in the aggregate and taking into account volume for the different products, cover 50 percent (or such higher percentage as the Secretary may specify) of all such types of products, the Secretary shall reject such bid. The volume for such types of products may be determined in accordance with such data (which may be market based data) as the Secretary recognizes.
(11) No administrative or judicial review
(Aug. 14, 1935, ch. 531, title XVIII, §1847, as added Pub. L. 105–33, title IV, §4319(a), Aug. 5, 1997, 111 Stat. 392
; amended Pub. L. 106–113, div. B, §1000(a)(6) [title III, §321(c)], Nov. 29, 1999, 113 Stat. 1536
, 1501A-366; Pub. L. 108–173, title III, §302(b)(1), Dec. 8, 2003, 117 Stat. 2224
; Pub. L. 110–275, title I, §§145(a)(1), 154(a)(1), (b)(2), (3), (c)(2)(A), (B), (d)(1), (3), (4), July 15, 2008, 122 Stat. 2547
, 2560, 2565-2568; Pub. L. 111–148, title VI, §6410(a), Mar. 23, 2010, 124 Stat. 773
; Pub. L. 114–10, title V, §522(a), (b)(1), Apr. 16, 2015, 129 Stat. 176
, 177; Pub. L. 114–255, div. A, title V, §5004(b)(1), Dec. 13, 2016, 130 Stat. 1191.)
The Federal Food, Drug, and Cosmetic Act, referred to in subsec. (a)(2)(A), is act June 25, 1938, ch. 675, 52 Stat. 1040
, as amended, which is classified generally to chapter 9 (§301 et seq.) of Title 21, Food and Drugs. For complete classification of this Act to the Code, see section 301 of Title 21 and Tables.
The Federal Advisory Committee Act, referred to in subsec. (c)(4), is Pub. L. 92–463, Oct. 6, 1972, 86 Stat. 770
, as amended, which is set out in the Appendix to Title 5, Government Organization and Employees.
A prior section 1395w–3, act Aug. 14, 1935, ch. 531, title XVIII, §1847, as added July 1, 1988, Pub. L. 100–360, title II, §202(j), 102 Stat. 719
; amended Oct. 13, 1988, Pub. L. 100–485, title VI, §608(d)(5)(I), 102 Stat. 2414
, provided for appointment of Prescription Drug Payment Review Commission by Director of Congressional Office of Technology Assessment, prior to repeal by Pub. L. 101–234, title II, §201(a), (c), Dec. 13, 1989, 103 Stat. 1981
, effective Jan. 1, 1990.
2016-Subsec. (a)(2)(A). Pub. L. 114–255 substituted ", excluding" for "and excluding" and inserted before period at end ", and excluding drugs and biologicals described in section 1395u(o)(1)(D) of this title".
Pub. L. 114–10, title V, §522(b)(2), Apr. 16, 2015, 129 Stat. 177
, provided that: "Nothing in the amendment made by paragraph (1) [amending this section] shall be construed as affecting the authority of the Secretary of Health and Human Services to require State licensure of an entity under the Medicare competitive acquisition program under section 1847 of the Social Security Act (42 U.S.C. 1395w–3) before the date of the enactment of this Act [Apr. 16, 2015]."
Pub. L. 108–173, title III, §302(b)(3), Dec. 8, 2003, 117 Stat. 2230
, as amended by Pub. L. 110–275, title I, §154(c)(1), July 15, 2008, 122 Stat. 2565
Pub. L. 108–173, title III, §302(e), Dec. 8, 2003, 117 Stat. 2233
, as amended by Pub. L. 110–275, title I, §154(c)(2)(C), July 15, 2008, 122 Stat. 2566
, provided that: "The Inspector General of the Department of Health and Human Services shall conduct a study to determine the extent to which (if any) suppliers of covered items of durable medical equipment that are subject to the competitive acquisition program under section 1847 of the Social Security Act [42 U.S.C. 1395w–3], as amended by subsection (a) [probably should be (b)(1)], are soliciting physicians to prescribe certain brands or modes of delivery of covered items based on profitability. Not later than July 1, 2011, the Inspector General shall submit to Congress a report on such study."
Pub. L. 105–33, title IV, §4319(c), Aug. 5, 1997, 111 Stat. 394
, provided that: "The Comptroller of the United States shall study the effectiveness of the establishment of competitive acquisition areas under section 1847(a) of the Social Security Act [42 U.S.C. 1395w–3(a)], as added by this section."